Acumen Pharmaceuticals, Inc.

SEC 4 · Filed

0001628280-26-003347Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jan 22, 2026

Sale by Zuga Matt

Security
Common Stock
Code
S
Shares
1,687
Price per share
1.86
Structured facts
{
  "code": "S",
  "date": "2026-01-22",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024."
  },
  "owners": [
    {
      "cik": "0001790214",
      "name": "Zuga Matt",
      "roles": [
        "officer"
      ],
      "title": "CFO \u0026 Chief Business Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "304924",
  "price": "1.86",
  "row": 2,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "1687",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Jan 21, 2026

Sale by Zuga Matt

Security
Common Stock
Code
S
Shares
2,473
Price per share
1.81Reported 1.8072
Structured facts
{
  "code": "S",
  "date": "2026-01-21",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024.",
    "F2": "The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7650 to $1.8700. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
  },
  "owners": [
    {
      "cik": "0001790214",
      "name": "Zuga Matt",
      "roles": [
        "officer"
      ],
      "title": "CFO \u0026 Chief Business Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "306611",
  "price": "1.8072",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "2473",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}